Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity: early-phase trial registry
1 of 4 indexed Recurrent Adenoid Cystic Carcinoma of the Oral Cavity trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity: 4 US clinical trials tracked, 1 recruiting.
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Sanjiv Sam Gambhir, running 1 of these trials.
Enrollment posture brief
Registry condition recurrent-adenoid-cystic-carcinoma-of-the-oral-cavity
OPEN 1 | RECR 25% | LATE 0 | EARLY 3 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Recurrent Adenoid Cystic Carcinoma of the Oral Cavity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Ohio State University Comprehensive Cancer Center
NCT01473784
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
National Cancer Institute (NCI)
NCT00397384
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
Sanjiv Sam Gambhir
NCT01806675
Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer
Fox Chase Cancer Center
NCT01637194
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Recurrent Adenoid Cystic Carcinoma of the Oral Cavity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Recurrent Adenoid Cystic Carcinoma of the Oral Cavity trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Recurrent Adenoid Cystic Carcinoma of the Oral Cavity page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Recurrent Adenoid Cystic Carcinoma of the Oral Cavity trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Sanjiv Sam Gambhir sponsors the most Recurrent Adenoid Cystic Carcinoma of the Oral Cavity trials on record, review their full trial history before evaluating a specific study. See Sanjiv Sam Gambhir's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Recurrent Adenoid Cystic Carcinoma of the Oral Cavity condition card totals 4 registered trials; most-linked intervention laboratory biomarker analysis; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.